Genetic variants of cancer‑associated genes analyzed using next‑generation sequencing in small sporadic vestibular schwannomas

Takeshi Fujita(Kobe University), Katsumi Doi(Kindai University), Kazuko Sakai(Kindai University Sakai Hospital), Hajime Koyama(The University of Tokyo), Yujiro Hoshi(Mitsui Memorial Hospital), Kazuto Nishio(Kindai University Sakai Hospital), Yasuhiro Osaki(Kindai University), Natsumi Uehara(Kobe University), Mitsuo Satõ(Kindai University Hospital), Kazuya Saito(Izumi City General Hospital), Anjin Mori(Kindai University)
Oncology Letters
February 8, 2023
10.3892/ol.2023.13707
Cited by 3

Related Papers

Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab
|Science Translational Medicine|2011|670
Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment
|Annals of Oncology|2017|294
B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity
|Clinical Cancer Research|2018|169
Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site
|Journal of Clinical Oncology|2019|168
Activation of HER Family Signaling as a Mechanism of Acquired Resistance to ALK Inhibitors in EML4-ALK–Positive Non–Small Cell Lung Cancer
|Clinical Cancer Research|2012|156